However, neither PIK-75 nor the other CDK7/9 inhibitors were as cytotoxic as daunorubicin against the mouse MLL-AF9 AMLs, despite reducing MCL-1 protein levels in a dose-dependent manner, even in the Mcl-1tg/MLL-AF9 tumours. This evidence concerns the gene KMT2A and neoplasm.